Research Projects
NanoNextNL: Microdevices for Chemical Processing (10C)
Micronit is working as part of a dedicated team to develop the next generation of scalable microstructured reactors focussing on the functionalisation of these microreactors for technically and commercially relevant applications in the chemical processing industry. The NanoNextNL 10C programme consists of 2 closely related, clustered projects focussing on:
1. Channel functionalization (e.g. wetting control, catalyst implementation)
2. Scalable microstructured reactors
The work of Micronit is directed towards the production of scalable microstructured reactors, with the aim to cover the complete range of channel sizes from 10 μm (researchscale) to several millimetres (required for production). The challenge is to obtain a thorough understanding of scaling issues, both as a direct influence on the reaction itself and as a factor affecting reactor performance. This latter effect will especially comes into play when creating stacked networks of parallel channels, where thermal management and fluid distribution are important factors. Focus will be directed to converting reactions requiring high pressure and temperature into microreactor format, especially gas-liquid reactions where batch reactions pose safety challenges.
NirionPlus
The goal of the NirionPlus project is to develop a point-of-care device that enables kidney patients to measure sodium, potassium and creatinine levels in their own blood and urine samples in a fast and effective way.
This project is funded by EFRO (Europees Fonds voor Regionale ontwikkeling), provincie Overijssel and regio Twente.
LCAOS – Lung cancer artificial olfactory system
The LCAOS project will develop and test a new diagnostic tool, able to detect: (I) the presence of lung cancer (LC), and (II) an increased risk of a patient developing LC in the future. Diagnostic tests currently available are unsuitable for widespread screening because they are costly, occasionally miss tumors, are not time-efficient, nor free of complications. LCAOS will overcome these problems by using an approach based on volatile biomarkers emitted from cell membranes.
More information can be found on the project website http://www.lcaos.eu/
The research receives funding from the FP7-Health Program (grant agreement no. 258868).
